Log in to save to my catalogue

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological...

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_279e4a0c446f4e368e11ad84795c5d49

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

About this item

Full title

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

Publisher

Basel: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2021-08, Vol.11 (8), p.1214

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation reaction of nicotinamide, using S-adenosyl-L-methionine as the methyl donor. Enzyme overexpression has been described in many non-neoplastic diseases, as well as in a wide range of solid malignancies. This review aims to report and discuss evidence available in scientific literatur...

Alternative Titles

Full title

The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_279e4a0c446f4e368e11ad84795c5d49

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_279e4a0c446f4e368e11ad84795c5d49

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom11081214

How to access this item